Exagen Inc
NASDAQ:XGN 4:00:00 PM EDT
| Market Cap (Intraday) | 49.90M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $2.96 |
| 50-Day MA | $2.84 |
| 200-Day MA | $2.08 |
Exagen Inc Stock, NASDAQ:XGN
1261 Liberty Way, Suite C, Vista, California 92081
United States of America
Phone: +1.760.560.1501
Number of Employees: 179
Description
Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.